|
XenoPort says Glaxo breached Horizant contract
Reuters … off deal if GSK continues to default Jan 25 (Reuters) – XenoPort Inc said its partner GlaxoSmithKline Plc has breached a contractual obligation to maximise the sales of their drug to treat restless legs syndrome (RLS) and achieve a sales milestone. |
View full post on restless leg syndrome – Google News
